A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy
Authors:
- Jae Ho LeeJLJae Ho Lee
- Ga-Young ParkGPGa-Young Park
- Sung Hak ChunSCSung Hak Chun
- Jeong Yun HanJHJeong Yun Han
- Sung Dae KimSKSung Dae Kim
- Janet LeeJLJanet Lee
- Chang-Woo LeeCLChang-Woo Lee
- Kwangmo YangKYKwangmo Yang
- Chang Geun LeeCLChang Geun Lee
- 1 January 2013
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 430 (4) , 1329-1333
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (50594-2011, 50597-2012)
- National Research Foundation
This publication has 31 references indexed in Scilit:
- Cancer stem cells as the relevant biomass for drug discoveryCurrent Opinion in Pharmacology, 2010
- Tumour-initiating cells: challenges and opportunities for anticancer drug discoveryNature Reviews Drug Discovery, 2009
- Cancer Stem Cells in Solid Tumors: An OverviewSeminars in Radiation Oncology, 2009
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- Identification and expansion of human colon-cancer-initiating cellsNature, 2006
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006
- Prospective Identification of Tumorigenic Prostate Cancer Stem CellsCancer Research, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994